BioMed Research International

Copyright © 2014 Nathália Santos Serrão de Castro and Marcelo de Oliveira Lima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. D. Lacerda and W. C. Pfeiffer, “Mercury from gold mining in the Amazon environment an overview,” Química Nova, vol. 15, pp. 155–160, 1992. View at Google Scholar
2. M. Lodenius and O. Malm, “Mercury in the Amazon,” Reviews of Environmental Contamination and Toxicology, vol. 157, pp. 25–52, 1998. View at Google Scholar · View at Scopus
3. L. Chapman and H. M. Chan, “The influence of nutrition on methyl mercury intoxication,” Environmental Health Perspectives, vol. 108, no. 1, pp. 29–56, 2000. View at Google Scholar · View at Scopus
4. J. C. Wasserman, S. Hacon, and M. A. Wasserman, “Biogeochemistry of mercury in the Amazonian environment,” Ambio, vol. 32, no. 5, pp. 336–342, 2003. View at Google Scholar · View at Scopus
5. E. C. de Oliveira Santos, I. M. de Jesus, E. da Silva Brabo et al., “Exposição ao mercúrio e ao arsênio em Estados da Amazônia: síntese dos estudos do Instituto Evandro Chagas/FUNASA Exposure to mercury and arsenic in studies by the Evandro Chagas,” Revista Brasileira de Epidemiologia, vol. 6, no. 2, pp. 171–185, 2003. View at Publisher · View at Google Scholar
6. J. G. Dorea, “Fish are central in the diet of Amazonian riparians: should we worry about their mercury concentrations?” Environmental Research, vol. 92, no. 3, pp. 232–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
7. A. Gonçalves and N. N. da Silva e Gonçalves, “Exposição humana ao mercúrio na Amazônia brasileira: uma perspectiva histórica,” Pan American Journal of Public Health, vol. 15, pp. 415–419, 2004. View at Google Scholar
8. C. J. Passos and D. Mergler, “Human mercury exposure and adverse health effects in the Amazon: a review,” Cadernos de Saúde Pública, vol. 24, supplement 4, pp. 503–520, 2008. View at Google Scholar
9. F. L. Barbieri and J. Gardon, “Hair mercury levels in Amazonian populations: spatial distribution and trends,” International Journal of Health Geographics, vol. 8, article 71, 2009. View at Publisher · View at Google Scholar · View at Scopus
10. K. D. Tew, Y. Manevich, C. Grek, Y. Xiong, J. Uys, and D. M. Townsend, “The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 299–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
11. Z. Rezaei, I. Saadat, and M. Saadat, “Association between three genetic polymorphisms of glutathione S-transferase Z1 (GSTZ1) and susceptibility to bipolar disorder,” Psychiatry Research, vol. 198, pp. 166–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
12. K. T. Schroer, A. M. Gibson, U. Sivaprasad et al., “Downregulation of glutathione S-transferase pi in asthma contributes to enhanced oxidative stress,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 539–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
13. T. Ramprasath, P. Senthil Murugan, A. D. Prabakaran, P. Gomathi, A. Rathinavel, and G. S. Selvam, “Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes,” Biochemical and Biophysical Research Communications, vol. 407, no. 1, pp. 49–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
14. J. D. Hayes, J. U. Flanagan, and I. R. Jowsey, “Glutathione transferases,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 51–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
15. P.-J. Jakobsson, R. Morgenstern, J. Mancini, A. Ford-Hutchinson, and B. Persson, “Common structural features of MAPEG—a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism,” Protein Science, vol. 8, no. 3, pp. 689–692, 1999. View at Google Scholar · View at Scopus
16. P. G. Board and D. Menon, “Glutathione transferases, regulators of cellular metabolism and physiology,” Biochimica et Biophysica Acta, vol. 1830, pp. 3267–3288, 2013. View at Publisher · View at Google Scholar
17. J. M. Goodrich and N. Basu, “Variants of glutathione s-transferase pi 1 exhibit differential enzymatic activity and inhibition by heavy metals,” Toxicology in Vitro, vol. 26, no. 4, pp. 630–635, 2012. View at Publisher · View at Google Scholar · View at Scopus
18. C.-J. Chung, Y.-S. Pu, C.-T. Su, C.-Y. Huang, and Y.-M. Hsueh, “Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma,” Science of the Total Environment, vol. 409, no. 3, pp. 465–470, 2011. View at Publisher · View at Google Scholar · View at Scopus
19. B. Mannervik, P. G. Board, J. D. Hayes, I. Listowsky, and W. R. Pearson, “Nomenclature for mammalian soluble glutathione transferases,” Methods in Enzymology, vol. 401, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
20. B. Mannervik, P. Alin, and C. Guthenberg, “Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 21, pp. 7202–7206, 1985. View at Google Scholar · View at Scopus
21. R. Polimanti, C. Carbonia, I. Baessoa et al., “Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems,” Gene, vol. 512, no. 1, pp. 102–107, 2013. View at Publisher · View at Google Scholar
22. P. K. Borah, P. Shankarishan, and J. Mahanta, “Glutathione S-transferase M1 and T1 gene polymorphisms and risk of hypertension in tea garden workers of North-East India,” Genetic Testing and Molecular Biomarkers, vol. 15, no. 11, pp. 771–776, 2011. View at Publisher · View at Google Scholar · View at Scopus
23. A. Karban, N. Krivoy, H. Elkin et al., “Non-jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency,” Digestive Diseases and Sciences, vol. 56, no. 7, pp. 2081–2087, 2011. View at Publisher · View at Google Scholar · View at Scopus
24. M. A. Chiurillo, P. Griman, L. Santiago, K. Torres, Y. Moran, and L. Borjas, “Distribution of GSTM1, GSTT1, GSTP1 and TP53 disease-associated gene variants in Native and Urban Venezuelan populations,” Gene, vol. 531, no. 1, pp. 106–111, 2013. View at Publisher · View at Google Scholar
25. P. A. Gaspar, M. H. Hutz, F. M. Salzano et al., “Polymorphisms of CYP1A1, CYP2E1, GSTM1, GSTT1, and TP53 genes in Amerindians,” American Journal of Physical Anthropology, vol. 119, no. 3, pp. 249–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
26. L. M. V. Nogueira, “A magnitude da tuberculose e os itinerários terapêuticos dos Mundurukus do Pará na Amazônia brasileira. xvi,” 162f, 2011.
27. M. D. N. Klautau-Guimarães, R. D'Ascenção, F. A. Caldart et al., “Analysis of genetic susceptibility to mercury contamination evaluated through molecular biomarkers in at-risk Amazon Amerindian populations,” Genetics and Molecular Biology, vol. 832, no. 4, pp. 827–832, 2005. View at Google Scholar · View at Scopus
28. C. O. de Hiragi, A. L. Miranda-Vilela, D. M. S. Rocha, S. F. de Oliveira, A. Hatagima, and M. N. de Klautau-Guimarães, “Superoxide dismutase, catalase, glutathione peroxidase and gluthatione s-transferases M1 and T1 gene polymorphisms in three brazilian population groups,” Genetics and Molecular Biology, vol. 34, no. 1, pp. 11–18, 2011. View at Google Scholar · View at Scopus
29. J.-F. Bach, “Infections and autoimmune diseases,” Journal of Autoimmunity, vol. 25, pp. 74–80, 2005. View at Publisher · View at Google Scholar · View at Scopus
30. X. Zhou and H. Zhang, “Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases Autophagy in immunity,” Autophagy, vol. 8, pp. 1286–1299, 2012. View at Publisher · View at Google Scholar
31. H. R. Wins, D. B. Prize, and A. Diseases, “Dietary salt linked to autoimmune diseases,” Science, vol. 339, p. 1132, 2012. View at Google Scholar
32. K. Nagamine, P. Peterson, H. S. Scott et al., “Positional cloning of the APECED gene,” Nature Genetics, vol. 17, no. 4, pp. 393–398, 1997. View at Google Scholar · View at Scopus
33. J. Zhang, H. Liu, Z. Liu et al., “A functional alternative splicing mutation in AIRE gene causes autoimmune polyendocrine syndrome type 1,” PLoS ONE, vol. 8, no. 1, Article ID e53981, 2013. View at Publisher · View at Google Scholar
34. T. Matsuo, Y. Noguchi, M. Shindo et al., “Regulation of human autoimmune regulator (AIRE) gene translation by miR-220b,” Gene, vol. 530, no. 1, pp. 19–25, 2013. View at Publisher · View at Google Scholar
35. E. M. Akirav, N. H. Ruddle, and K. C. Herold, “The role of AIRE in human autoimmune disease,” Nature Reviews Endocrinology, vol. 7, no. 1, pp. 25–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
36. A. Goris, I. Pauwels, and B. Dubois, “Progress in multiple sclerosis genetics,” Current Genomics, vol. 13, no. 8, pp. 646–663, 2012. View at Publisher · View at Google Scholar
37. G. C. Ebers, K. Kukay, D. E. Bulman et al., “A full genome search in multiple sclerosis,” Nature Genetics, vol. 13, no. 4, pp. 472–476, 1996. View at Publisher · View at Google Scholar · View at Scopus
38. J. L. Haines, H. A. Terwedow, K. Burgess et al., “Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group,” Human Molecular Genetics, vol. 7, no. 8, pp. 1229–1234, 1998. View at Google Scholar · View at Scopus
39. D. A. Dyment, B. M. Herrera, M. Z. Cader et al., “Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance,” Human Molecular Genetics, vol. 14, no. 14, pp. 2019–2026, 2005. View at Publisher · View at Google Scholar · View at Scopus
40. I. A. F. van der Mei, A.-L. Ponsonby, T. Dwyer et al., “Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study,” British Medical Journal, vol. 327, no. 7410, pp. 316–320, 2003. View at Google Scholar · View at Scopus
41. J. J. Kragt, B. M. van Amerongen, J. Killestein et al., “Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women,” Multiple Sclerosis, vol. 15, no. 1, pp. 9–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
42. K. M. Spach, F. E. Nashold, B. N. Dittel, and C. E. Hayes, “IL-10 signaling is essential for 1,25-dihydroxyvitamin D 3-mediated inhibition of experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 177, no. 9, pp. 6030–6037, 2006. View at Google Scholar · View at Scopus
43. J. L. Huynh and P. Casaccia, “Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment,” The Lancet Neurology, vol. 12, no. 2, pp. 195–206, 2013. View at Publisher · View at Google Scholar
44. F. W. Miller, K. M. Pollard, C. G. Parks et al., “Criteria for environmentally associated autoimmune diseases,” Journal of Autoimmunity, vol. 39, pp. 253–258, 2013. View at Google Scholar
45. C. Castro and M. Gourley, “Diagnostic testing and interpretation of tests for autoimmunity,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S238–S247, 2010. View at Publisher · View at Google Scholar · View at Scopus
46. M. Fiducia, R. Lauretta, R. Lunghi, S. Kyanvash, and S. Pallotti, “Hashimoto's thyroiditis and autoimmunity parameters: descriptive study,” Minerva Medica, vol. 98, no. 2, pp. 95–99, 2007. View at Google Scholar · View at Scopus
47. M. G. Tektonidou, M. Anapliotou, P. Vlachoyiannopoulos, and H. M. Moutsopoulos, “Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases,” Annals of the Rheumatic Diseases, vol. 63, no. 9, pp. 1159–1161, 2004. View at Publisher · View at Google Scholar · View at Scopus
48. M. P. Manns, A. J. Czaja, J. D. Gorham et al., “Diagnosis and management of autoimmune hepatitis,” Hepatology, vol. 51, no. 6, pp. 2193–2213, 2010. View at Publisher · View at Google Scholar · View at Scopus
49. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
50. E. M. Tan, T. E. W. Feltkamp, J. S. Smolen et al., “Range of antinuclear antibodies in “healthy” individuals,” Arthritis and Rheumatism, vol. 40, no. 9, pp. 1601–1611, 1997. View at Publisher · View at Google Scholar · View at Scopus
51. S. Wananukul, W. Voramethkul, Y. Kaewopas, and O. Hanvivatvong, “Prevalence of positive antinuclear antibodies in healthy children,” Asian Pacific Journal of Allergy and Immunology, vol. 23, no. 2-3, pp. 153–157, 2005. View at Google Scholar · View at Scopus
52. M. Lian, J. Hua, L. Sheng, and D. K. Qui, “Prevalence and significance of autoantibodies in patients with alcoholic liver disease,” Journal of Digestive Diseases, vol. 14, no. 7, pp. 396–401, 2013. View at Publisher · View at Google Scholar
53. A. M. Abeles and M. Abeles, “The clinical utility of a positive antinuclear antibody,” The American Journal of Medicine, vol. 126, no. 4, pp. 342–348, 2013. View at Publisher · View at Google Scholar
54. R. H. Shmerling, “Autoantibodies in systemic lupus erythematosus—there before you know it,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1499–1500, 2003. View at Publisher · View at Google Scholar · View at Scopus
55. I. A. Silva, J. F. Nyland, A. Gorman et al., “Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in amazon populations in Brazil: a cross-sectional study,” Environmental Health: A Global Access Science Source, vol. 3, article 11, 2004. View at Publisher · View at Google Scholar · View at Scopus
56. M. F. Alves, N. Fraiji, A. Barbosa et al., “Fish consumption, mercury exposure and serum antinuclear antibody in Amazonians,” International Journal of Environmental Health Research, vol. 16, no. 4, pp. 255–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
57. R. M. Gardner, J. F. Nyland, I. A. Silva, A. Maria Ventura, J. Maria de Souza, and E. K. Silbergeld, “Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study,” Environmental Research, vol. 110, no. 4, pp. 345–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
58. E. O. Santos, E. C. B. Loureiro, I. M. Brabo et al., “Diagnóstico das condições de saúde de uma comunidade garimpeira na região do Rio Tapajós, Itaituba, Pará, Brasil, 1992,” Cadernos de Saúde Pública, vol. 11, pp. 212–225, 1995. View at Google Scholar
59. R. C. de Sena Couto, V. M. Câmara, and P. C. Sabroza, “Intoxicação mercurial: resultados preliminares em duas áreas garimpeiras—PA,” Cadernos de Saúde Pública, vol. 4, no. 3, 1988. View at Publisher · View at Google Scholar
60. A. A. Couto, V. S. Calvosa, R. Lacerda, F. Castro, E. Santa Rosa, and J. M. Nascimento, “Control of malaria transmission in a gold-mining area in Amapá State, Brazil, with participation by private enterprise,” Cadernos de Saúde Pública, vol. 17, no. 4, pp. 897–907, 2001. View at Google Scholar · View at Scopus
61. A. A. M. Fernandes, L. J. D. M. Carvalho, G. M. Zanini et al., “Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region,” Clinical and Vaccine Immunology, vol. 15, no. 4, pp. 650–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
62. “Situação epidemiológica da malária no Brasil, 2000 a 2011,” Boletim Epidemiológico, vol. 44, no. 1, pp. 1–16, 2013.
63. R. N. Q. Leão, Medicina Tropical e Infectologia na Amazônia, 1590, (Samauma Editorial, 2013).
64. U. E. C. Confalonieri, C. Margonari, and A. F. Quintão, “Environmental change and the dynamics of parasitic diseases in the Amazon,” Acta Tropica, vol. 129, pp. 33–41, 2014. View at Publisher · View at Google Scholar
65. M. C. Suárez-Mutis, P. Cuervo, F. M. S. Leoratti et al., “Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 49, no. 3, pp. 159–164, 2007. View at Google Scholar · View at Scopus
66. T. J. Marcano, A. Morgado, C. E. Tosta, and J. R. Coura, “Cross-sectional study defines difference in malaria morbidity in two yanomami communities on Amazonian boundary between Brazil and Venezuela,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 4, pp. 369–376, 2004. View at Google Scholar · View at Scopus
67. M. da Silva-Nunes and M. U. Ferreira, “Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the “symptomatic” vs “asymptomatic” dichotomy,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 3, pp. 341–347, 2007. View at Google Scholar · View at Scopus
68. R. S. U. da Silva, F. T. de Carvalho, A. B. dos Santos et al., “Malária no Município de Cruzeiro do Sul, Estado do Acre, Brasil: aspectos epidemiológicos, clínicos e laboratoriais,” Revista Pan-Amazônica de Saúde, vol. 3, no. 1, pp. 45–54, 2012. View at Google Scholar
69. M. R. C. Monteiro, M. C. Ribeiro, and S. C. Fernandes, “Aspectos clínicos e epidemiológicos da malária em um hospital universitário de Belém, Estado do Pará, Brasil,” Revista Pan-Amazônica de Saúde, vol. 4, pp. 33–43, 2013. View at Google Scholar
70. M. A. Alexandre, C. O. Ferreira, A. M. Siqueira et al., “Severe Plasmodium vivax malaria, Brazilian Amazon,” Emerging Infectious Diseases, vol. 16, no. 10, pp. 1611–1614, 2010. View at Publisher · View at Google Scholar · View at Scopus
71. B. B. Andrade, A. Reis-Filho, S. M. Souza-Neto et al., “Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance,” Malaria Journal, vol. 9, no. 1, article 13, 2010. View at Publisher · View at Google Scholar · View at Scopus
72. N. D. Karunaweera, G. E. Grau, P. Gamage, R. Carter, and K. N. Mendis, “Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3200–3203, 1992. View at Google Scholar · View at Scopus
73. J.-W. Park, S.-H. Park, J.-S. Yeom et al., “Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hepatic dysfunction,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 4, pp. 687–691, 2003. View at Publisher · View at Google Scholar · View at Scopus
74. W. S. M. Braga, E. B. da Silva, R. A. B. Souza, and C. E. Tosta, “Soroprevalência da infecção pelo vírus da hepatite B e pelo plasmódio em Lábrea, Amazonas: estimativa da ocorrência de prováveis coinfecções,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 38, 2005. View at Google Scholar
75. W. S. M. Braga, R. A. B. de Souza, E. B. da Silva, J. C. F. da Fonseca, and C. E. Tosta, “Co-infecção humana pelo plasmódio e o vírus da hepatite B: aspectos clínicos, sorológicos e imunológicos,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 39, pp. 27–31, 2006. View at Google Scholar
76. B. B. Andrade, C. J. N. Santos, L. M. Camargo et al., “Hepatitis B infection is associated with asymptomatic malaria in the brazilian Amazon,” PLoS ONE, vol. 6, no. 5, Article ID e19841, 2011. View at Publisher · View at Google Scholar · View at Scopus
77. F. H. Alencar, L. K. O. Yuyama, and M. E. L. Gutierrez, “Situação nutricional e alimentar de portadores de malária residentes no Amazonas—Brasil,” Acta Amazonica, vol. 31, pp. 227–236, 2001. View at Google Scholar
78. V. S. dos Santana, L. C. Lavezzo, A. Mondini et al., “Concurrent dengue and malaria in the Amazon region,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 43, pp. 508–511, 2010. View at Publisher · View at Google Scholar
79. J. F. Nyland, S. B. Wang, D. L. Shirley et al., “Fetal and maternal immune responses to methylmercury exposure: a cross-sectional study,” Environmental Research, vol. 111, no. 4, pp. 584–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
80. J. F. Nyland, M. Fillion, F. Barbosa Jr. et al., “Biomarkers of methylmercury exposure immunotoxicity among fish consumers in Amazonian Brazil,” Environmental Health Perspectives, vol. 119, no. 12, pp. 1733–1738, 2011. View at Google Scholar · View at Scopus
81. Y. Miyanari, C. Ziegler-Birling, and M. E. Torres-Padilla, “Live visualization of chromatin dynamics with fluorescent TALEs,” Nature Structural & Molecular Biology, vol. 20, pp. 1321–1324, 2013. View at Publisher · View at Google Scholar
82. S. Agarwal and A. Rao, “Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation,” Immunity, vol. 9, no. 6, pp. 765–775, 1998. View at Publisher · View at Google Scholar · View at Scopus
83. A. O'Garra and N. Arai, “The molecular basis of T helper 1 and T helper 2 cell differentiation,” Trends in Cell Biology, vol. 10, no. 12, pp. 542–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
84. P. Hajkova, K. Ancelin, T. Waldmann et al., “Chromatin dynamics during epigenetic reprogramming in the mouse germ line,” Nature, vol. 452, no. 7189, pp. 877–882, 2008. View at Publisher · View at Google Scholar · View at Scopus
85. A. Mazumder, T. Roopa, A. Basu, L. Mahadevan, and G. V. Shivashankar, “Dynamics of chromatin decondensation reveals the structural integrity of a mechanically prestressed nucleus,” Biophysical Journal, vol. 95, no. 6, pp. 3028–3035, 2008. View at Publisher · View at Google Scholar · View at Scopus
86. M. Fenech, “Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs),” Food and Chemical Toxicology, vol. 40, no. 8, pp. 1113–1117, 2002. View at Publisher · View at Google Scholar · View at Scopus
87. J. M. Rodríguez-Vargas, M. J. Magana, C. Ruiz et al., “ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy,” Cell Research, vol. 22, pp. 1181–1198, 2012. View at Publisher · View at Google Scholar
88. R. Masuma, S. Kashima, M. Kurasaki, and T. Okuno, “Effects of UV wavelength on cell damages caused by UV irradiation in PC12 cells,” Journal of Photochemistry and Photobiology B: Biology, vol. 125, pp. 202–208, 2013. View at Publisher · View at Google Scholar
89. T. Iyama and D. M. Wilson, “DNA repair mechanisms in dividing and non-dividing cells,” DNA Repair, vol. 12, no. 8, pp. 620–636, 2013. View at Publisher · View at Google Scholar
90. K. D. Mills, D. O. Ferguson, and F. W. Alt, “The role of DNA breaks in genomic instability and tumorigenesis,” Immunological Reviews, vol. 194, pp. 77–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
91. J. Liu, J. Kim, and P. Oberdoerffer, “Metabolic modulation of chromatin: implications for DNA repair and genomic integrity,” Frontiers in Genetics, vol. 4, p. 182, 2013. View at Google Scholar
92. S. Skerfving, K. Hansson, and J. Lindsten, “Chromosome breakage in humans exposed to methyl mercury through fish consumption,” Archives of Environmental Health, vol. 21, no. 2, pp. 133–139, 1970. View at Google Scholar · View at Scopus
93. V. Mabille, H. Roels, P. Jacquet, and R. Lauwerys, “Cytogenetic examination of leucocytes of workers exposed to mercury vapour,” International Archives of Occupational and Environmental Health, vol. 53, no. 3, pp. 257–260, 1984. View at Google Scholar · View at Scopus
94. M. I. M. Amorim, D. Mergler, M. O. Bahia et al., “Cytogenetic damage related to low levels of methyl mercury contamination in the Brazilian Amazon,” Anais da Academia Brasileira de Ciencias, vol. 72, no. 4, pp. 496–507, 2000. View at Google Scholar · View at Scopus